Redhill Biopharma reported $72.58M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Adamis Pharmaceuticals ADMP:US USD 10.09M 5.23M
Cara Therapeutics CARA:US USD 186.78M 10.61M
Cronos Group Inc CRON:CN USD 963.31M 62.74M
Intra Cellular Therapies ITCI:US USD 759.76M 29.45M